Rhumbline Advisers Acutus Medical, Inc. Transaction History

Rhumbline Advisers

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.49 - $1.3 $5,996 - $15,909	-12,238 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.39 - $3.92 $1,456 - $4,108	1,048 Added 9.37%	12,238 $17,000
Q4 2021 Feb 10, 2022	BUY	$3.1 - $8.97 $310 - $897	100 Added 0.9%	11,190 $38,000
Q3 2021 Nov 12, 2021	BUY	$8.35 - $16.99 $6,053 - $12,317	725 Added 6.99%	11,090 $98,000
Q2 2021 Aug 05, 2021	BUY	$11.59 - $17.73 $120,130 - $183,771	10,365 New	10,365 $176,000
Q1 2021 May 06, 2021	SELL	$12.97 - $34.0 $127,183 - $333,404	-9,806 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$22.87 - $32.1 $36,409 - $51,103	1,592 Added 19.38%	9,806 $283,000
Q3 2020 Nov 12, 2020	BUY	$24.5 - $37.65 $201,243 - $309,257	8,214 New	8,214 $245,000

Ticker AFIB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,370,300
Market Cap $1.99M
Description
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conv...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.